Do analysts rate ACB or CGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Does the media refer more to ACB or CGC?

In the previous week, Canopy Growth had 10 more articles in the media than Aurora Cannabis. MarketBeat recorded 12 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.63 beat Canopy Growth's score of 0.51 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Canopy Growth 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CRON or CGC?

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 19.58%. Given Cronos Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Does the media refer more to CRON or CGC?

In the previous week, Canopy Growth had 8 more articles in the media than Cronos Group. MarketBeat recorded 12 mentions for Canopy Growth and 4 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.88 beat Canopy Growth's score of 0.51 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Canopy Growth 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CGC or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend CGC or SNDL?

SNDL has a consensus target price of $5.00, suggesting a potential upside of 264.96%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings and valuation, CGC or SNDL?

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Canopy Growth $251.01M 1.69 -$190.29M -$0.59 N/A SNDL $677.32M 0.52 -$11.29M -$0.03 N/A

Is CGC or SNDL more profitable?

SNDL has a net margin of -1.19% compared to Canopy Growth's net margin of -75.27%. SNDL's return on equity of -1.02% beat Canopy Growth's return on equity. Company Net Margins Return on Equity Return on Assets Canopy Growth -75.27% -26.95% -17.20% SNDL -1.19% -1.02% -0.85%

Do analysts prefer CGC or TLRY?

Tilray Brands has a consensus target price of $11.50, suggesting a potential upside of 159.59%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts clearly believe Tilray Brands is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media prefer CGC or TLRY?

In the previous week, Tilray Brands had 15 more articles in the media than Canopy Growth. MarketBeat recorded 27 mentions for Tilray Brands and 12 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.51 beat Tilray Brands' score of 0.45 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Tilray Brands 8 Very Positive mention(s) 3 Positive mention(s) 12 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Canopy Growth (CGC) Competitors

$0.95 0.00 (-0.14%)

Closing price 07/1/2026 04:00 PM Eastern

Extended Trading

$0.97 +0.02 (+2.25%)

As of 08:23 AM Eastern

Compare

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

Should you buy Canopy Growth stock or one of its competitors? MarketBeat compares Canopy Growth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Canopy Growth compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$320.59M	0.54	-$88.13M	-$1.56	N/A
Canopy Growth	$251.01M	1.69	-$190.29M	-$0.59	N/A

In the previous week, Canopy Growth had 10 more articles in the media than Aurora Cannabis. MarketBeat recorded 12 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.63 beat Canopy Growth's score of 0.51 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Canopy Growth	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Aurora Cannabis has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.79, suggesting that its stock price is 21% less volatile than the broader market.

Aurora Cannabis has a net margin of -33.57% compared to Canopy Growth's net margin of -75.27%. Aurora Cannabis' return on equity of 0.10% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-33.57%	0.10%	0.07%
Canopy Growth	-75.27%	-26.95%	-17.20%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

Canopy Growth beats Aurora Cannabis on 8 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

In the previous week, Canopy Growth had 8 more articles in the media than Cronos Group. MarketBeat recorded 12 mentions for Canopy Growth and 4 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.88 beat Canopy Growth's score of 0.51 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Canopy Growth	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	7.28	-$9.45M	$0.01	286.00
Canopy Growth	$251.01M	1.69	-$190.29M	-$0.59	N/A

Cronos Group has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.79, suggesting that its stock price is 21% less volatile than the broader market.

Cronos Group has a net margin of -1.14% compared to Canopy Growth's net margin of -75.27%. Cronos Group's return on equity of -1.26% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Canopy Growth	-75.27%	-26.95%	-17.20%

Cronos Group currently has a consensus price target of $2.30, indicating a potential downside of 19.58%. Given Cronos Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Cronos Group beats Canopy Growth on 13 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Organigram Global?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

Canopy Growth has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market.

Organigram Global has lower revenue, but higher earnings than Canopy Growth. Organigram Global is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.69	-$190.29M	-$0.59	N/A
Organigram Global	$185.07M	0.78	-$17.70M	-$0.13	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Canopy Growth had 11 more articles in the media than Organigram Global. MarketBeat recorded 12 mentions for Canopy Growth and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.89 beat Canopy Growth's score of 0.51 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Canopy Growth	Positive
Organigram Global	Very Positive

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Comparatively, 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Organigram Global has a net margin of -9.22% compared to Canopy Growth's net margin of -75.27%. Organigram Global's return on equity of -13.41% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Organigram Global	-9.22%	-13.41%	-9.09%

Summary

Organigram Global beats Canopy Growth on 9 of the 14 factors compared between the two stocks.

How does Canopy Growth compare to SNDL?

Canopy Growth (NASDAQ:CGC) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

In the previous week, Canopy Growth had 11 more articles in the media than SNDL. MarketBeat recorded 12 mentions for Canopy Growth and 1 mentions for SNDL. SNDL's average media sentiment score of 1.89 beat Canopy Growth's score of 0.51 indicating that SNDL is being referred to more favorably in the news media.

Company	Overall Sentiment
Canopy Growth	Positive
SNDL	Very Positive

3.3% of Canopy Growth shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.69	-$190.29M	-$0.59	N/A
SNDL	$677.32M	0.52	-$11.29M	-$0.03	N/A

SNDL has a consensus target price of $5.00, suggesting a potential upside of 264.96%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

SNDL has a net margin of -1.19% compared to Canopy Growth's net margin of -75.27%. SNDL's return on equity of -1.02% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
SNDL	-1.19%	-1.02%	-0.85%

Canopy Growth has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, SNDL has a beta of 0.92, meaning that its share price is 8% less volatile than the broader market.

Summary

SNDL beats Canopy Growth on 9 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Tilray Brands?

Canopy Growth (NASDAQ:CGC) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Canopy Growth has a net margin of -75.27% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Tilray Brands	-156.51%	-3.31%	-2.42%

Canopy Growth has higher revenue and earnings than Tilray Brands. Canopy Growth is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.69	-$190.29M	-$0.59	N/A
Tilray Brands	$210.48M	2.45	-$2.19B	-$13.65	N/A

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Comparatively, 0.8% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Tilray Brands has a consensus target price of $11.50, suggesting a potential upside of 159.59%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts clearly believe Tilray Brands is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Tilray Brands had 15 more articles in the media than Canopy Growth. MarketBeat recorded 27 mentions for Tilray Brands and 12 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.51 beat Tilray Brands' score of 0.45 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Tilray Brands	8 Very Positive mention(s)	3 Positive mention(s)	12 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Canopy Growth has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.89, indicating that its share price is 89% more volatile than the broader market.

Summary

Tilray Brands beats Canopy Growth on 11 of the 16 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CGC vs. The Competition

Export

Metric	Canopy Growth	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$426M	$8.32B	$6.79B	$12.60B
Dividend Yield	N/A	2.51%	2.66%	6.14%
P/E Ratio	-1.61	15.70	27.43	25.27
Price / Sales	1.69	6.71	537.94	99.25
Price / Cash	N/A	17.65	47.99	59.26
Price / Book	0.84	3.55	11.02	6.62
Net Income	-$190.29M	$226.25M	$3.57B	$336.83M
7 Day Performance	3.90%	1.12%	2.90%	3.25%
1 Month Performance	-10.50%	-1.20%	3.71%	0.92%
1 Year Performance	-20.28%	3.20%	34.39%	27.62%

Canopy Growth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CGC Canopy Growth	1.1698 of 5 stars	$0.95 -0.1%	N/A	-16.0%	$426M	$251.01M	N/A	3,150	Analyst Upgrade
ACB Aurora Cannabis	1.0525 of 5 stars	$2.87 -2.0%	N/A	-34.7%	$179.74M	$247.82M	N/A	1,028
CRON Cronos Group	1.3729 of 5 stars	$2.65 -2.2%	$2.30 -13.2%	+49.0%	$1.01B	$146.59M	265.27	450
OGI Organigram Global	0.8277 of 5 stars	$0.96 -0.5%	N/A	-22.7%	$135.80M	$185.07M	N/A	1,139	Positive News
SNDL SNDL	3.8155 of 5 stars	$1.40 -1.4%	$5.00 +257.1%	+12.3%	$365.50M	$677.32M	N/A	2,751	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CGC) was last updated on 7/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canopy Growth (CGC) Competitors

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

How does Canopy Growth compare to Aurora Cannabis?

Summary

How does Canopy Growth compare to Cronos Group?

Summary

How does Canopy Growth compare to Organigram Global?

Summary

How does Canopy Growth compare to SNDL?

Summary

How does Canopy Growth compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CGC vs. The Competition

Canopy Growth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Canopy Growth (CGC) Competitors

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

How does Canopy Growth compare to Aurora Cannabis?

Do institutionals and insiders believe in ACB or CGC?

Which has preferable valuation & earnings, ACB or CGC?

Does the media refer more to ACB or CGC?

Which has more volatility and risk, ACB or CGC?

Is ACB or CGC more profitable?

Do analysts rate ACB or CGC?

Summary

How does Canopy Growth compare to Cronos Group?

Does the media refer more to CRON or CGC?

Which has preferable valuation & earnings, CRON or CGC?

Which has more volatility and risk, CRON or CGC?

Is CRON or CGC more profitable?

Do analysts rate CRON or CGC?

Do institutionals and insiders believe in CRON or CGC?

Summary

How does Canopy Growth compare to Organigram Global?

Which has more volatility and risk, CGC or OGI?

Which has better earnings and valuation, CGC or OGI?

Do analysts recommend CGC or OGI?

Does the media prefer CGC or OGI?

Do institutionals and insiders hold more shares of CGC or OGI?

Is CGC or OGI more profitable?

Summary

How does Canopy Growth compare to SNDL?

Does the media prefer CGC or SNDL?

Do institutionals and insiders hold more shares of CGC or SNDL?

Which has better earnings and valuation, CGC or SNDL?

Do analysts recommend CGC or SNDL?

Is CGC or SNDL more profitable?

Which has more volatility and risk, CGC or SNDL?

Summary

How does Canopy Growth compare to Tilray Brands?

Is CGC or TLRY more profitable?

Which has preferable earnings and valuation, CGC or TLRY?

Do insiders & institutionals hold more shares of CGC or TLRY?

Do analysts prefer CGC or TLRY?

Does the media prefer CGC or TLRY?

Which has more risk & volatility, CGC or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CGC vs. The Competition

Canopy Growth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools